93 related articles for article (PubMed ID: 38658748)
1. Prostaglandin E2 in the Tumor Microenvironment, a Convoluted Affair Mediated by EP Receptors 2 and 4.
Santiso A; Heinemann A; Kargl J
Pharmacol Rev; 2024 May; 76(3):388-413. PubMed ID: 38697857
[TBL] [Abstract][Full Text] [Related]
2. CD8
Prokhnevska N; Cardenas MA; Valanparambil RM; Sobierajska E; Barwick BG; Jansen C; Reyes Moon A; Gregorova P; delBalzo L; Greenwald R; Bilen MA; Alemozaffar M; Joshi S; Cimmino C; Larsen C; Master V; Sanda M; Kissick H
Immunity; 2023 Jan; 56(1):107-124.e5. PubMed ID: 36580918
[TBL] [Abstract][Full Text] [Related]
3. Antitumor progenitor exhausted CD8
Lan X; Mi T; Alli S; Guy C; Djekidel MN; Liu X; Boi S; Chowdhury P; He M; Zehn D; Feng Y; Youngblood B
Nat Immunol; 2024 Jun; 25(6):1046-1058. PubMed ID: 38816618
[TBL] [Abstract][Full Text] [Related]
4. Fluorescence tracking demonstrates T cell recirculation is transiently impaired by radiation therapy to the tumor.
Kramer G; Blair T; Bambina S; Kaur AP; Alice A; Baird J; Friedman D; Dowdell AK; Tomura M; Grassberger C; Piening BD; Crittenden MR; Gough MJ
Sci Rep; 2024 May; 14(1):11909. PubMed ID: 38789721
[TBL] [Abstract][Full Text] [Related]
5. Post-resolution macrophages shape long-term tissue immunity and integrity in a mouse model of pneumococcal pneumonia.
Feehan KT; Bridgewater HE; Stenkiewicz-Witeska J; De Maeyer RPH; Ferguson J; Mack M; Brown J; Ercoli G; Mawer CM; Akbar AN; Glanville JRW; Jalali P; Bracken OV; Nicolaou A; Kendall AC; Sugimoto MA; Gilroy DW
Nat Commun; 2024 May; 15(1):4326. PubMed ID: 38773113
[TBL] [Abstract][Full Text] [Related]
6. The aged tumor microenvironment limits T cell control of cancer.
Chen ACY; Jaiswal S; Martinez D; Yerinde C; Ji K; Miranda V; Fung ME; Weiss SA; Zschummel M; Taguchi K; Garris CS; Mempel TR; Hacohen N; Sen DR
Nat Immunol; 2024 Jun; 25(6):1033-1045. PubMed ID: 38745085
[TBL] [Abstract][Full Text] [Related]
7. LILRB4 signalling in leukaemia cells mediates T cell suppression and tumour infiltration.
Deng M; Gui X; Kim J; Xie L; Chen W; Li Z; He L; Chen Y; Chen H; Luo W; Lu Z; Xie J; Churchill H; Xu Y; Zhou Z; Wu G; Yu C; John S; Hirayasu K; Nguyen N; Liu X; Huang F; Li L; Deng H; Tang H; Sadek AH; Zhang L; Huang T; Zou Y; Chen B; Zhu H; Arase H; Xia N; Jiang Y; Collins R; You MJ; Homsi J; Unni N; Lewis C; Chen GQ; Fu YX; Liao XC; An Z; Zheng J; Zhang N; Zhang CC
Nature; 2018 Oct; 562(7728):605-609. PubMed ID: 30333625
[TBL] [Abstract][Full Text] [Related]
8. Tumor-Reactive CD8+ T Cells Enter a TCF1+PD-1- Dysfunctional State.
Roetman JJ; Erwin MM; Rudloff MW; Favret NR; Detrés Román CR; Apostolova MKI; Murray KA; Lee TF; Lee YA; Philip M
Cancer Immunol Res; 2023 Dec; 11(12):1630-1641. PubMed ID: 37844197
[TBL] [Abstract][Full Text] [Related]
9. Dapl1 controls NFATc2 activation to regulate CD8
Zhu L; Zhou X; Gu M; Kim J; Li Y; Ko CJ; Xie X; Gao T; Cheng X; Sun SC
Nat Cell Biol; 2022 Jul; 24(7):1165-1176. PubMed ID: 35773432
[TBL] [Abstract][Full Text] [Related]
10. Stem-like CD4
Sato Y; Jain A; Ohtsuki S; Okuyama H; Sturmlechner I; Takashima Y; Le KC; Bois MC; Berry GJ; Warrington KJ; Goronzy JJ; Weyand CM
Sci Transl Med; 2023 Sep; 15(712):eadh0380. PubMed ID: 37672564
[TBL] [Abstract][Full Text] [Related]
11. COX2-dependent suppression of anticancer immunity.
Lira MC; Galluzzi L; Vanpouille-Box C
Trends Cancer; 2024 May; ():. PubMed ID: 38821853
[TBL] [Abstract][Full Text] [Related]
12. PGE
Morotti M; Grimm AJ; Hope HC; Arnaud M; Desbuisson M; Rayroux N; Barras D; Masid M; Murgues B; Chap BS; Ongaro M; Rota IA; Ronet C; Minasyan A; Chiffelle J; Lacher SB; Bobisse S; Murgues C; Ghisoni E; Ouchen K; Bou Mjahed R; Benedetti F; Abdellaoui N; Turrini R; Gannon PO; Zaman K; Mathevet P; Lelievre L; Crespo I; Conrad M; Verdeil G; Kandalaft LE; Dagher J; Corria-Osorio J; Doucey MA; Ho PC; Harari A; Vannini N; Böttcher JP; Dangaj Laniti D; Coukos G
Nature; 2024 May; 629(8011):426-434. PubMed ID: 38658764
[TBL] [Abstract][Full Text] [Related]
13. Intratumoral Tcf1
Siddiqui I; Schaeuble K; Chennupati V; Fuertes Marraco SA; Calderon-Copete S; Pais Ferreira D; Carmona SJ; Scarpellino L; Gfeller D; Pradervand S; Luther SA; Speiser DE; Held W
Immunity; 2019 Jan; 50(1):195-211.e10. PubMed ID: 30635237
[TBL] [Abstract][Full Text] [Related]
14. Prostaglandin E₂ down-regulates the expression of CD25 on bovine T cells, and this effect is mediated through the EP4 receptor.
Maślanka T; Spodniewska A; Barski D; Jasiecka A; Zuśka-Prot M; Ziółkowski H; Markiewicz W; Jaroszewski JJ
Vet Immunol Immunopathol; 2014 Aug; 160(3-4):192-200. PubMed ID: 25001909
[TBL] [Abstract][Full Text] [Related]
15. Prostaglandin E Receptor 4 Antagonist in Cancer Immunotherapy: Mechanisms of Action.
Take Y; Koizumi S; Nagahisa A
Front Immunol; 2020; 11():324. PubMed ID: 32210957
[TBL] [Abstract][Full Text] [Related]
16. TCF1 in T cell immunity: a broadened frontier.
Zhao X; Shan Q; Xue HH
Nat Rev Immunol; 2022 Mar; 22(3):147-157. PubMed ID: 34127847
[TBL] [Abstract][Full Text] [Related]
17. PGE
Lacher SB; Dörr J; de Almeida GP; Hönninger J; Bayerl F; Hirschberger A; Pedde AM; Meiser P; Ramsauer L; Rudolph TJ; Spranger N; Morotti M; Grimm AJ; Jarosch S; Oner A; Gregor L; Lesch S; Michaelides S; Fertig L; Briukhovetska D; Majed L; Stock S; Busch DH; Buchholz VR; Knolle PA; Zehn D; Dangaj Laniti D; Kobold S; Böttcher JP
Nature; 2024 May; 629(8011):417-425. PubMed ID: 38658748
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
